Explain possible side effects and interaction/safety considerations for iron infusion without overstating causality or efficacy.
Part of vitamins & minerals side effects.
Source
Clinical statements on this page are taken from the SAHPRA-approved patient information leaflet (approved 20/11/2023) and professional information (approved 20/11/2023) for this product: patient information leaflet, professional information. Retrieved 2026-09-03. Where this page and the approved leaflet differ, the leaflet is correct.
What is iron infusion?
Iron-Infusion contains the active ingredient Ferric derisomaltose.
- Active ingredient — Ferric derisomaltose
- Registration number — 46/8.3/0166; 46/8.3/0167; 46/8.3/0168
- Registration holder — Acino Pharma (Pty) Ltd
It is approved for:
- MONOFER contains a combination of iron and derisomaltose (a chain of sugar molecules)
- MONOFER is used in the treatment of low levels of iron (sometimes called ‘iron deficiency’) when you cannot take iron treatment by mouth or if your body requires the iron very quickly
Possible side effects of iron infusion
Not everyone gets side effects. The effects below are those listed in the South African approved leaflet, grouped using the leaflet’s own frequency wording.
About these frequency terms
This leaflet groups effects on the very common/common/uncommon scale.
Common side effects
- nausea
- rash
- skin reactions at or near the injection site including redness of the skin, swelling, burning, pain, bruising, brown discolouration, leakage to the tissue around the site of infusion, irritation
Uncommon side effects
- hypersensitivity reactions with potential shortness of breath and bronchospasm
- numbness
- distortion of the sense of taste
- blurred vision
- loss of consciousness
- wheezing
- pain in and around the stomach (abdominal pain), being sick (vomiting), constipation, diarrhoea, impaired digestion
- flushing, sweating, fever, feeling cold, shivering
- dizziness
- fatigue
- increased heart rate
- Chest pain, back pain, pain in your muscles or joints, muscle spasms
- low or high blood pressure
- Itching, hives, skin inflammation
- flushing, sweating, fever, feeling cold, shivering
- headache
- unusual feeling on the surface of your body (pins and needles)
- low level of phosphate in the blood
- infection
- increased liver enzymes
- local inflammation of a vein
- skin exfoliation
- general feeling of discomfort (malaise)
- tremor
- hoarseness
- seizure
- altered mental status
Not known side effects
- Skin discoloration at other areas of the body than the injection site
Interactions and medicines to check
The approved leaflet names these interactions.
- Always tell your health care provider if you are taking any other medicine
- (This includes all complementary or traditional medicines.) In particular tell your doctor, nurse or pharmacist if you are taking iron containing medicines that you take by mouth
- You should not take iron by mouth until at least 5 days after the last injection of MONOFER
- Having blood tests done while you are receiving MONOFER: MONOFER may affect the results of some blood tests to measure bilirubin and calcium
- If you have to take a blood test, inform the doctor that you are being treated with MONOFER
- If you are not sure if the above applies to you, talk to your doctor, nurse or pharmacist before receiving MONOFER
Bring the actual products to the conversation
A pharmacist can check for interactions much faster from the packaging than from remembered names.
Who should use extra caution?
The approved leaflet identifies the following cautions and factors.
Do not use it at all if
- If you are allergic (hypersensitive) to ferric derisomaltose or any of the other ingredients of MONOFER (listed in section 6)
- If you have experienced serious allergic (hypersensitive) reactions to other injectable iron products
- If you have anaemia that is not caused by low levels of iron (deficiency), such as haemolytic anaemia listed in point 6
- If you have too much iron (overload) or a problem in the way your body uses iron (e.g. haemochromatosis, haemosiderosis)
- If you have an ongoing bacterial infection in your blood
Use with care, and tell your doctor, if
- If you have known allergies to any other medicine
- If you have an illness of your immune system, such as systemic lupus erythematosus (a serious disease of the skin), or rheumatoid arthritis
- If you have severe asthma or you have a history of asthma or problems with allergies, eczema or inflammation
- If you have reduced liver function
- If you have an acute or chronic infection
- Incorrect administration of MONOFER may cause leakage of the product at the injection site, which may lead to irritation of the skin and potentially long-lasting brown discolouration at the site of injection. The administration must be stopped immediately when this occurs. Children and adolescents MONOFER is for adults only. Children and adolescents younger than 18 years of age should not be administered MONOFER. If you are not sure if any of the above applies to you, talk to your doctor or healthcare professional before being administered MONOFER
Pregnancy and breastfeeding
- If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, please consult your doctor, pharmacist or other health care provider for advice before being administered MONOFER
- If you become pregnant during treatment, you must ask your doctor for advice
- Your doctor will decide whether or not you should be given MONOFER
- If you are breastfeeding, ask your doctor for advice before you are given MONOFER
Dose, timing and other factors that can affect side effects
The approved leaflet identifies the following cautions and factors.
Do not use it at all if
- If you are allergic (hypersensitive) to ferric derisomaltose or any of the other ingredients of MONOFER (listed in section 6)
- If you have experienced serious allergic (hypersensitive) reactions to other injectable iron products
- If you have anaemia that is not caused by low levels of iron (deficiency), such as haemolytic anaemia listed in point 6
- If you have too much iron (overload) or a problem in the way your body uses iron (e.g. haemochromatosis, haemosiderosis)
- If you have an ongoing bacterial infection in your blood
Use with care, and tell your doctor, if
- If you have known allergies to any other medicine
- If you have an illness of your immune system, such as systemic lupus erythematosus (a serious disease of the skin), or rheumatoid arthritis
- If you have severe asthma or you have a history of asthma or problems with allergies, eczema or inflammation
- If you have reduced liver function
- If you have an acute or chronic infection
- Incorrect administration of MONOFER may cause leakage of the product at the injection site, which may lead to irritation of the skin and potentially long-lasting brown discolouration at the site of injection. The administration must be stopped immediately when this occurs. Children and adolescents MONOFER is for adults only. Children and adolescents younger than 18 years of age should not be administered MONOFER. If you are not sure if any of the above applies to you, talk to your doctor or healthcare professional before being administered MONOFER
Pregnancy and breastfeeding
- If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, please consult your doctor, pharmacist or other health care provider for advice before being administered MONOFER
- If you become pregnant during treatment, you must ask your doctor for advice
- Your doctor will decide whether or not you should be given MONOFER
- If you are breastfeeding, ask your doctor for advice before you are given MONOFER
Serious symptoms and warning signs
This leaflet does not set out a separate list of serious side effects. The general warning signs below apply to any medicine.
General warning signs that apply to any medicine
Call for emergency help now if any of these happen
- Difficulty breathing, wheezing, or tightness in the throat or chest
- Swelling of the face, lips, tongue or throat
- A widespread rash with blistering or peeling skin, or sores in the mouth, eyes or genitals
- Fainting, collapse, or a sudden severe drop in alertness
- Chest pain, or sudden weakness or numbness on one side of the body
- A fit (seizure), or confusion that comes on suddenly
In South Africa call 10177 for an ambulance, or 112 from a mobile phone. Go to your nearest emergency department if it is faster. Do not wait to see whether the symptom settles.
What to do if side effects occur
If you think you are having a side effect, the response depends on how severe it is. Use the warning signs above first — if any of those apply, treat it as urgent.
If the symptom is severe or frightening
Get medical help immediately. Call 10177 for an ambulance, or 112 from a mobile phone, or go to the nearest emergency department. Take the product and its packaging with you if you can.
If the symptom is mild but bothering you
- Write down what the symptom is, when it started, and how it relates to when you take the product
- Check the leaflet that came with the product to see whether the symptom is listed
- Speak to your pharmacist — for many questions this is the fastest route to a useful answer
- Contact the prescriber if the symptom is affecting your daily life or is not settling
Do not stop a prescribed treatment on your own
Stopping some treatments suddenly causes its own problems, and the condition being treated may get worse. If you want to stop, ask a pharmacist or doctor how to do it safely — they can usually offer an alternative.
You can also report a suspected side effect in South Africa. Reporting does not replace getting medical advice, and you do not need to be certain the product was the cause.
How to report a suspected side effect in South Africa
South Africa has an official system for reporting suspected side effects, run by the South African Health Products Regulatory Authority (SAHPRA). Reports from the public and from healthcare professionals are how safety signals get detected after a product is already in use.
Who can report
Anyone can report — you do not have to be a healthcare professional, and you do not need to prove that the product caused the problem. A suspicion is enough. Patients, caregivers and family members can all submit a report.
What to have ready
- The name of the product, its strength and form, and the batch number if you have it
- Why it was being used, and when it was started and stopped
- What the suspected reaction was, when it began, and how long it lasted
- Any other medicines, supplements or remedies being used at the same time
- Basic details about the person affected — age and sex are usually enough
How to report
SAHPRA accepts adverse reaction reports through its e-Services reporting system and through the Med Safety mobile app. Healthcare professionals can also report through the same routes. Current forms and access points are published on the SAHPRA site.
- SAHPRA Health Products Vigilance — the main vigilance and reporting hub
- SAHPRA e-Services — current adverse reaction reporting access
Reporting is not a substitute for medical care
If someone is unwell now, get medical help first and report afterwards. Urgent symptoms always take precedence over paperwork.
For a fuller walkthrough see how to report an adverse drug reaction.
Related pages
← Back to more supplement side effects.
Report a side effect
If you think you have had a side effect, you can report a suspected side effect in South Africa. Report a suspected side effect through the appropriate SAHPRA pathway where relevant.
Information only
This page gives general medicine-safety information for people in South Africa. It is not a diagnosis and not personalised medical advice. It cannot tell you whether a symptom you are having is caused by a particular product. Speak to a pharmacist or doctor about your own situation, and do not stop or change a prescribed treatment on the basis of a web page.
Editorial status: draft — not for publication
Brief SE-00157 · build rank 157 · Phase 1 · Tier 1. Every evidence slot on this page must be completed from the SAHPRA-approved source and the page signed off by a qualified clinical or pharmacy reviewer before it is published. Target length 1,500–2,200 words.